Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Designing a Non Invasive Gene Therapy for Treating Alzheimer's Disease

FY 2014-15

Summary
Alzheimer's disease is hypothesized to be caused by the accumulation of toxic forms of the protein amyloid-beta (AB) in the brain. These toxic variants can lead to neuronal death. As such, significant pre-clinical and clinical research has looked at mitigating the effects of harmful AB using neutralizing antibodies. Clinically though, many of these studies have resulted in limited success. This can be attributed, in part, to the blood brain barrier (BBB), a vascular gateway which prevents the entry of most antibodies and drugs into the brain. Due to the BBB, current clinical approaches require the administering of high doses of antibody into the blood stream, a practice which can sometimes lead to severe side effects. To address this problem, in this project we outline the use of Magnetic Resonance Imaging guided Focused Ultrasound (MRIgFUS), a non-invasive approach, which can temporarily open the blood brain barrier in a specified location. In a relevant mouse model, we will deliver the gene for an antibody using a viral vector, directed to key regions of the brain by MRIgFUS. This gene cassette has been designed to become active and express only in specific types of brain cells. In this way, following a single treatment, we propose to enable the brain to continuously produce a therapeutic antibody. We hope to demonstrate prolonged neutralization of toxic AB proteins, prevention of neuronal death, and rescue of cognitive decline.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
331232
Name
Silburt Joseph L
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Designing a Non Invasive Gene Therapy for Treating Alzheimer's Disease
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Aging; Alzheimer'S Disease; Gene Therapy; Immunotherapy; Magnetic Resonance Imaging Guided Focused Ultrasound; Viral Vectors
Abstract
Alzheimer's disease is hypothesized to be caused by the accumulation of toxic forms of the protein amyloid-beta (AB) in the brain. These toxic variants can lead to neuronal death. As such, significant pre-clinical and clinical research has looked at mitigating the effects of harmful AB using neutralizing antibodies. Clinically though, many of these studies have resulted in limited success. This can be attributed, in part, to the blood brain barrier (BBB), a vascular gateway which prevents the entry of most antibodies and drugs into the brain. Due to the BBB, current clinical approaches require the administering of high doses of antibody into the blood stream, a practice which can sometimes lead to severe side effects. To address this problem, in this project we outline the use of Magnetic Resonance Imaging guided Focused Ultrasound (MRIgFUS), a non-invasive approach, which can temporarily open the blood brain barrier in a specified location. In a relevant mouse model, we will deliver the gene for an antibody using a viral vector, directed to key regions of the brain by MRIgFUS. This gene cassette has been designed to become active and express only in specific types of brain cells. In this way, following a single treatment, we propose to enable the brain to continuously produce a therapeutic antibody. We hope to demonstrate prolonged neutralization of toxic AB proteins, prevention of neuronal death, and rescue of cognitive decline.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Silburt, Joseph L
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~